.png)
The Almac Group is an established CDMO providing integrated CMC services, bridging the gap between drug substance and product development.
An established provider of both drug substance (advanced intermediates and API – small molecules and peptides) and drug product development services, we provide scientific continuity from a dedicated project team, resulting in significant time and cost savings.
We support drug substance and product analytics across all phases offering full lifecycle solutions for your unique drug format.
Through our continued investment in the expansion of our state-of-the-art services, Almac is your trusted CDMO to provide support across the product development lifecycle.